Abstract
The aim of this study is to explore how the patient's experience of their treatment influence withdrawal from BCG? And what are the strategies that could reduce patient withdrawal from BCG treatment?
Research problemThe cumulative treatment side effects of Bacillus Calmette-Guerin can be both physical and psychological. Bladder cancer accounts for over 10 000 new diagnosis annually in the United Kingdom. Therefore, this article attempts to explore the patient's experience of their treatment and how this influences their withdrawal from treatment.
Literature reviewA literature review was undertaken utilizing the CONSORT approach for reporting of research trials. Multiple databases were searched. The review showed that there is a paucity in the literature in the comprehensive understanding of the patient's experience of undertaking BCG treatment and potential subsequent withdrawal.
MethodologyA qualitative data was collected using semi-structured interviews. Six interviews were conducted on participants who withdrew from intravesical BCG treatment. An inductive approach was used to thematically analyse the data.
ResultsNVivo 10 was used to manage the data. Following an in-depth analysis of the interview transcripts when all available data had been extracted and coded, four key themes emerged. These four themes were identified as: “treatment concerns”; “withdrawal influencers”; “unmet needs”; and what appeared to be “treatment bereavement” were concerning to the participants.
ConclusionsThis article presents the results from the qualitative phase of a larger mixed methods study. The data produced from the interviews highlights themes and factors that cause patients to withdraw from BCG treatment early. These areas show the requirement for additional support in areas of communication, information giving and decision making. This study also identified a “novel” concept of “treatment bereavement”, which described the feelings of loss when withdrawing early.
Original language | English |
---|---|
Pages (from-to) | 106-114 |
Number of pages | 9 |
Journal | International Journal of Urological Nursing |
Volume | 14 |
Issue number | 3 |
Early online date | 10 Jun 2020 |
DOIs | |
Publication status | Published - 1 Nov 2020 |
Externally published | Yes |
Keywords
- bacillus Calmette-Guerin (BCG)
- bladder cancer
- early withdrawal
- intravesical treatment
- non-muscle invasive bladder cancer
- treatment bereavement
- urothelial cancer